Periodic Reporting for period 1 - MELISSA (Mobile Artificial Intelligence Solution for Diabetes Adaptive Care)

Achieving near-normal glycaemic control remains highly challenging for most people with type 1 or type 2 diabetes requiring intensive insulin treatment, despite advances in insulin delivery and glucose monitoring technology. Daily insulin needs for people with diabetes (PwD)...